Document ID: chunk:federal_register_of_legislation:C2025C00156:section:92:p4
Version: federal_register_of_legislation:C2025C00156
Segment Type: section
Provision Reference: s 92 (pt 4/4)
Character Range: 489423–491454

necessary to give effect to the agreement; and
 (ii) invites the person to make written submissions to the Chief Executive Medicare, within a specified period of not less than 14 days after the notice is given, about why the Chief Executive Medicare should not notify the Director under paragraph (4)(da); and
 (b) consider any submissions made as mentioned in subparagraph (a)(ii).
 (5) A refusal of the Determining Authority to ratify the agreement does not prevent the Director and the person under review from entering into a further agreement under subsection (1).
 (6) The Director must not disclose to any Panel member (other than a Panel member consulted by the Director under paragraph 90(1)(a) in relation to the referral):
 (a) the content of any communications between the Director and the person under review in relation to proposals for an agreement under this section; or
 (b) whether any such communications have taken place.
 (6A) This section applies as if a reference in this section to a practitioner included a reference to a person who has been a practitioner.
 (7) In this section:
associated person, in relation to a person under review, has the meaning given by subsection 106U(5).
Part VII authority means any of the following authorities or approvals under Part VII of the National Health Act 1953:
 (a) the authority conferred on a medical practitioner by section 88 of that Act;
 (b) the approval of a dental practitioner as a participating dental practitioner under section 84A of that Act;
 (ba) the approval of an optometrist as an authorised optometrist under section 84AAB of that Act;
 (bb) the approval of an eligible midwife as an authorised midwife under section 84AAF of that Act;
 (bc) the approval of an eligible nurse practitioner as an authorised nurse practitioner under section 84AAJ of that Act;
 (c) the approval of a medical practitioner under section 92 of that Act;
 (d) the authority conferred on a medical practitioner by section 93 of that Act to supply pharmaceutical benefits.